# GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
Canonical URL: https://biopharmsignal.com/news/GNFT/genfit-annual-combined-general-meeting-of-june-15-2026-availability-of-preparatory-documents
Ticker: GNFT
Company: GENFIT
Source: GENFIT
Published: 2026-05-11 17:00 EST
Original Source URL: https://ir.genfit.com
## Summary

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the May 11, 2026

## Article Body
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the May 11, 2026
## Recent Company News
- 2026-05-25 16:00 EST — [GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026](https://biopharmsignal.com/news/GNFT/genfit-highlights-broad-scientific-and-strategic-presence-at-easl-congress-2026) — Source: GENFIT
- 2026-05-21 16:00 EST — [GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update](https://biopharmsignal.com/news/GNFT/genfit-reports-first-quarter-2026-financial-information-and-provides-a-corporate-update) — Source: GENFIT
- 2026-05-11 17:00 EST — [GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents](https://biopharmsignal.com/news/GNFT/genfit-annual-combined-general-meeting-of-june-15-2026-availability-of-preparatory-documents) — Source: GENFIT
- 2026-04-20 16:00 EST — [GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)](https://biopharmsignal.com/news/GNFT/genfit-publication-of-the-2026-extra-financial-report-fiscal-year-2025) — Source: GENFIT
- 2026-04-07 17:30 EST — [GENFIT Announces Publication of the 2025 Universal Registration Document](https://biopharmsignal.com/news/GNFT/genfit-announces-publication-of-the-2025-universal-registration-document) — Source: GENFIT
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)